Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Gerber

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2018
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level DataMatteo Lambertini, Halle C F Moore, Robert C F Leonard, et al.
Annals of Surgical Oncology|July 28, 2019
Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized TrialsDavid Krug, Bianca Lederer, Fenja Seither, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapyJenny Furlanetto, Volker Möbus, Andreas Schneeweiss, et al.
The Lancet. Oncology|February 13, 2016
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trialMichael Untch, Christian Jackisch, Andreas Schneeweiss, et al.
NPJ Breast Cancer|January 27, 2026
Axillary surgery in patients with sentinel node macrometastases: secondary results of the randomized INSEMA trialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer TrialThomas Karn, Tobias Meissner, Karsten E Weber, et al.
Breast Cancer Research and Treatment|June 5, 2017
First international consensus conference on standardization of oncoplastic breast conserving surgeryWalter P Weber, Savas D Soysal, Mahmoud El-Tamer, et al.
The Lancet. Oncology|May 6, 2014
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trialGunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German ExpertsChristian Jackisch, Nadia Harbeck, Jens Huober, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2018
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto StudyPeter A Fasching, Sibylle Loibl, Chunling Hu, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2018
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level DataMatteo Lambertini, Halle C F Moore, Robert C F Leonard, et al.
Annals of Surgical Oncology|July 28, 2019
Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized TrialsDavid Krug, Bianca Lederer, Fenja Seither, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapyJenny Furlanetto, Volker Möbus, Andreas Schneeweiss, et al.
The Lancet. Oncology|February 13, 2016
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trialMichael Untch, Christian Jackisch, Andreas Schneeweiss, et al.
NPJ Breast Cancer|January 27, 2026
Axillary surgery in patients with sentinel node macrometastases: secondary results of the randomized INSEMA trialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer TrialThomas Karn, Tobias Meissner, Karsten E Weber, et al.
Breast Cancer Research and Treatment|June 5, 2017
First international consensus conference on standardization of oncoplastic breast conserving surgeryWalter P Weber, Savas D Soysal, Mahmoud El-Tamer, et al.
The Lancet. Oncology|May 6, 2014
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trialGunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German ExpertsChristian Jackisch, Nadia Harbeck, Jens Huober, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2018
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto StudyPeter A Fasching, Sibylle Loibl, Chunling Hu, et al.
Pageof 18